The European Medicines Agency (EMA) celebrates 25th anniversary caring about public and animal health

Опубліковано 11.02.2020 о 15:44

“25 years is a significant milestone for EMA. Together with our partners and stakeholders from national authorities, EU institutions and civil society we harmonised and improved medicines’ evaluation, stimulated innovation, improved safety monitoring and management, fostered transparency and dialogue, built relationships with international partners, and helped to make medicines accessible to those who need them’’, said Guido Rasi, EMA’s Executive Director. “As we look to the future, we will continue to build on these strong foundations to deliver high-quality work for the benefit of public and animal health’’.

The European Medicines Agency (EMA) is a decentralized agency of the European Union established on 26 January 1995 and responsible for science assessment, surveillance and monitoring of medicines safety in the EU. EMA is a network organization that brings the best EU experts together to set up efficient and reliable system of assessment and control for human and veterinary medicines.

Success of EMA is based on collaboration in the frameworks of European medicines regulatory network – unique partnership between the European Commission, medicines regulatory authorities in the European Economic Area countries and EMA. Common work with interested parties including patients, healthcare professionals, academia and other experts encourages sharing knowledge, ideas and best practices with the aim of ensuring the highest standards in medicines regulation. 

 

More detailed information can be found via the following link https://www.ema.europa.eu/en/news/ema-celebrates-25-years-advancing-public-animal-health

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Print button Версія для друку

Попередня

Information on importing to Ukraine of antiviral medicines containing active substances oseltamivir and zanamivir

Наступна

Public report of the Head of the State Service of Ukraine on Medicines and Drugs Control (SMDC) scheduled for 21 February 2020